Home Periodic verification of results’ comparability between several analyzers: experience in the application of the EP31-A-IR guideline
Article
Licensed
Unlicensed Requires Authentication

Periodic verification of results’ comparability between several analyzers: experience in the application of the EP31-A-IR guideline

  • Leonor Guiñón ORCID logo EMAIL logo , Francisco J. Illana ORCID logo , Biel Cuevas , Marina Canyelles ORCID logo , Cecília Martínez-Bru ORCID logo and Álvaro García-Osuna ORCID logo
Published/Copyright: October 12, 2023

Abstract

Objectives

To assess the usefulness of the EP31-A-IR guideline published by the Clinical and Laboratory Standards Institute (CLSI) to perform the periodic verification of results’ comparability between several analyzers.

Methods

Twenty-four biochemistry parameters that could be measured in different analyzers were included: albumin, alkaline phosphatase, alanine aminotransferase, amylase, aspartate aminotransferase, calcium, chloride, C-reactive protein, creatine kinase, creatinine, direct bilirubin, gamma glutamyl transferase, glucose, lactate dehydrogenase, magnesium, phosphate, potassium, sodium, total bilirubin, total cholesterol, total protein, triglycerides, urea and uric acid. In accordance with the EP31-A-IR guideline: (1) Patient samples were selected considering the concentration or activity of interest. (2) Acceptance criteria were established specifically for each concentration or activity level. A quality specification based on biological variation or on state of the art was selected, considering the analytical performance of the available technology. (3) Maximum allowable differences (MAD) between analyzers were calculated. (4) Measurements were performed as stated in appendix B of the guideline. (5) Maximum differences between analyzers were calculated. Results were considered comparable when the maximum difference was less than or equal to the MAD.

Results

For the 24 parameters evaluated, any difference between analyzers exceeded the MAD.

Conclusions

The EP31-A-IR guideline proved to be useful for periodic verification of results’ comparability. However, it must be considered that, to be practicable, it may require to adjust the acceptance criteria in accordance to the analytical performance of the available technology; as well as the number of analytical measurements conforming to the laboratory resources.


Corresponding author: Leonor Guiñón, Quality Department, Laboratories, Hospital de la Santa Creu i Sant Pau, Sant Quintí 89 – 08041, Barcelona, Spain; Biochemistry Department, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Sant Quintí 89 – 08041, Barcelona, Spain; and Core Laboratory, Hospital de la Santa Creu i Sant Pau, Sant Quintí 89 – 08041, Barcelona, Spain, E-mail:

  1. Research ethics: Research involving human subjects complied with all relevant national regulations, institutional policies and is in accordance with the tenets of the Helsinki Declaration (as revised in 2013), and has been approved by the Ethics Committee of our Hospital (IIBSP-CED-2023-79).

  2. Informed consent: Not applicable.

  3. Author contributions: The authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Competing interests: The authors state no conflict of interest.

  5. Research funding: None declared.

  6. Data availability: The datasets generated during the current study are available from the corresponding author on reasonable request.

References

1. Clinical and Laboratory Standards Institute (CLSI). Measurement procedure comparison and bias estimation using patient samples. Approved guideline – CLSI document EP09-A3. Wayne, PA: CLSI; 2013.Search in Google Scholar

2. Braga, F, Panteghini, M. Commutability of reference and control materials: an essential factor for assuring the quality of measurements in Laboratory Medicine. Clin Chem Lab Med 2019;57:967–73. https://doi.org/10.1515/cclm-2019-0154.Search in Google Scholar PubMed

3. EN ISO 15189:2022. Medical laboratories – particular requirements for quality and competence. Geneva: ISO; 2022.Search in Google Scholar

4. Clinical and Laboratory Standards Institute (CLSI). Verification of comparability of patient results within one health care system. CLSI document EP31-A-IR. Wayne, PA: CLSI; 2012.Search in Google Scholar

5. Harris, EK. Statistical principles underlying analytic goal-setting in clinical chemistry. Am J Clin Pathol 1979;72:374–82.Search in Google Scholar

6. Fraser, CG, Petersen, PH. The importance of imprecision. Ann Clin Biochem 1991;28:207–11. https://doi.org/10.1177/000456329102800301.Search in Google Scholar PubMed

7. Aarsand, AK, Fernandez-Calle, P, Webster, C, Coskun, A, Gonzales-Lao, E, Diaz-Garzon, J, et al.. The EFLM biological variation database. Available from: https://biologicalvariation.eu/ [Accessed 18 Aug 2023].Search in Google Scholar

8. Minchinela, J, Ricós, C, Perich, C, Fernández-Calle, P, Alvarez, V, Domenech, M, et al.. Biological variation database and quality specifications for imprecision, bias and total error (desirable and minimum). The 2014 update. Available from: https://www.westgard.com/biodatabase-2014-update.htm [Accessed 18 Aug 2023].Search in Google Scholar

9. de Medio, EP, Borrás, AM, Quiles, JA, Castellví, JB, Bauzá, FR, García, AS, et al.. Minimum analytical quality consensus specifications in Spain. Comparison with previous, mandatory and biological. Rev Med Lab 2020;1:93–107.Search in Google Scholar

10. Molina, A, Guiñon, L, Perez, A, Segurana, A, Bedini, JL, Reverter, JC, et al.. State of the art vs biological variability: comparison on hematology parameters using Spanish EQAS data. Int J Lab Hematol 2018;40:284–91. https://doi.org/10.1111/ijlh.12783.Search in Google Scholar PubMed

11. Lee, EJ, Lee, E, Kim, M, Kim, HS, Lee, YK, Kang, HJ. Verification of the comparability of laboratory results from two instruments within one health care system according to Clinical and Laboratory Standard Institute EP31-A-IR. J Lab Med Qual Assur 2016;38:129–36. https://doi.org/10.15263/jlmqa.2016.38.3.129.Search in Google Scholar


Supplementary Material

This article contains supplementary material (https://doi.org/10.1515/cclm-2023-0994).


Received: 2023-09-07
Accepted: 2023-10-03
Published Online: 2023-10-12
Published in Print: 2024-02-26

© 2023 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Unraveling the mystery of blood groups and COVID-19
  4. Reviews
  5. Serum hepcidin levels in chronic liver disease: a systematic review and meta-analysis
  6. Platelet distribution width (PDW) as a significant correlate of COVID-19 infection severity and mortality
  7. Mini Reviews
  8. ABO blood group-related mechanism of infection of SARS-CoV-2: an overview of systematic reviews
  9. Opinion Paper
  10. Personalized laboratory medicine in the digital health era: recent developments and future challenges
  11. Guidelines and Recommendations
  12. Algorithm of differential diagnosis of anemia involving laboratory medicine specialists to advance diagnostic excellence
  13. General Clinical Chemistry and Laboratory Medicine
  14. Rescaling creatinine makes GFR estimation equations generally applicable across populations – validation results for the Lund-Malmö equation in a French cohort of sub-Saharan ancestry
  15. Periodic verification of results’ comparability between several analyzers: experience in the application of the EP31-A-IR guideline
  16. Machine learning to optimize cerebrospinal fluid dilution for analysis of MRZH reaction
  17. Diagnostic performance of automated red cell parameters in predicting bone marrow iron stores
  18. Reliability of hemoglobin A2 value as measured by the Premier Resolution system for screening of β-thalassemia carriers
  19. Amino acid sequence homology of monoclonal serum free light chain dimers and tissue deposited light chains in AL amyloidosis: a pilot study
  20. Development of high-performance point-of-care aqueous VEGF detection system and proof-of-concept validation in RVO patients
  21. Detection rate of IGF-1 variants and their implication to protein binding: study of over 240,000 patients
  22. Analysis of a second-tier test panel in dried blood spot samples using liquid chromatography-tandem mass spectrometry in Catalonia’s newborn screening programme
  23. Targeted quantitative lipidomic uncovers lipid biomarkers for predicting the presence of compensated cirrhosis and discriminating decompensated cirrhosis from compensated cirrhosis
  24. Reference Values and Biological Variations
  25. Establishment of reference intervals for free light chains and immunoglobulins in Saudi population
  26. Cancer Diagnostics
  27. A predictive and prognostic model for surgical outcome and prognosis in ovarian cancer computed by clinico-pathological and serological parameters (CA125, HE4, mesothelin)
  28. M-protein diagnostics in multiple myeloma patients using ultra-sensitive targeted mass spectrometry and an off-the-shelf calibrator
  29. Cardiovascular Diseases
  30. Bioactive adrenomedullin (bio-ADM) is associated with endothelial dysfunction in infants and children with complex congenital heart disease undergoing open-heart surgery on cardiopulmonary bypass
  31. Infectious Diseases
  32. Monocyte distribution width as an early predictor of short-term outcome in adult patients with sepsis
  33. Analytical and clinical evaluations of SNIBE Maglumi chemiluminescent immunoassay for the detection of SARS-CoV-2 antigen in salivary samples
  34. Letters to the Editor
  35. Predicting hemoglobinopathies using ChatGPT
  36. Managing the Quality Control of multiple instruments
  37. Lipid droplets may interfere with urinary red blood cell and crystal counts by urinary flow cytometry
  38. Assessment of the lipemia index determined by the Atellica CH 930 analyzer for the detection of monoclonal immunoglobulins
  39. Concerning quality demands of arterial partial pressure of oxygen
  40. Navigating between perpendicular drop and tangent skimming methods for M-protein quantification: a call for clarification of guidelines
  41. Early detection of peripheral invasive candidiasis further to cytographic interferences in Sysmex XN-9000 hematology analyzer
  42. Congress Abstracts
  43. Annual meeting of the Royal Belgian Society of Laboratory Medicine: “Symphony of the Heart”
Downloaded on 8.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2023-0994/pdf
Scroll to top button